Evidence map›Paper›PMID 32421895›Full record

ArticleAngewandte Chemie (International ed. in English)2020

PI by NMR: Probing CH-π Interactions in Protein-Ligand Complexes by NMR Spectroscopy.

Gerald Platzer, Moriz Mayer, Andreas Beier, Sven Brüschweiler, Julian E Fuchs, Harald Engelhardt, Leonhard Geist, Gerd Bader, Julia Schörghuber, Roman Lichtenecker and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Hidden Interactions: Quantum Perspectives in Drug Design.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  6. Leveraging relaxation-optimizedNature chemistry · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Synthesis of aChembiochem : a European journal of chemical biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Synthesis of aJournal of biomolecular NMR · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Gerald PlatzerChristian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Campus Vienna Biocenter 5, 1030, Vienna, Austria.ORCID 0000-0003-3466-0245
Moriz MayerBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0003-3432-4348
Andreas BeierChristian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Campus Vienna Biocenter 5, 1030, Vienna, Austria.ORCID 0000-0002-1934-8926
Sven BrüschweilerChristian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Campus Vienna Biocenter 5, 1030, Vienna, Austria.ORCID 0000-0003-2760-9767
Julian E FuchsBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0003-4322-9481
Harald EngelhardtBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0001-8170-1893
Leonhard GeistBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0002-3241-676X
Gerd BaderBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0002-8410-3415
Julia SchörghuberInstitute of Organic Chemistry, University of Vienna, Währingerstraße 38, 1090, Vienna, Austria.ORCID 0000-0002-9409-281X
Roman LichteneckerInstitute of Organic Chemistry, University of Vienna, Währingerstraße 38, 1090, Vienna, Austria.ORCID 0000-0003-2168-5216
Bernhard WolkerstorferBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0002-3023-2350
Dirk KesslerBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0001-6808-9011
Darryl B McConnellBoehringer Ingelheim RCV GmbH & Co. KG, Dr. Boehringer Gasse 5-11, 1121, Vienna, Austria.ORCID 0000-0002-2537-3458
Robert KonratChristian Doppler Laboratory for High-Content Structural Biology and Biotechnology, Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Campus Vienna Biocenter 5, 1030, Vienna, Austria.ORCID 0000-0001-6489-4080
Boehringer Ingelheim (Austria) · ATUniversity of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While CH-π interactions with target proteins are crucial determinants for the affinity of arguably every drug molecule, no method exists to directly measure the strength of individual CH-π interactions in drug-protein complexes. Herein, we present a fast and reliable methodology called PI (π interactions) by NMR, which can differentiate the strength of protein-ligand CH-π interactions in solution. By combining selective amino-acid side-chain labeling with

Indexed as

HumansMagnetic Resonance SpectroscopyModels, MolecularProteinsProteinsCH-π interactionsmedicinal chemistryNMR spectroscopyprotein-ligand interactionsstructure-based drug design

Identifiers

PMID32421895
PMCPMC7496880
OpenAlexW3043241433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.